IL207906A0 - Treatment for ocular-related disorders - Google Patents

Treatment for ocular-related disorders

Info

Publication number
IL207906A0
IL207906A0 IL207906A IL20790610A IL207906A0 IL 207906 A0 IL207906 A0 IL 207906A0 IL 207906 A IL207906 A IL 207906A IL 20790610 A IL20790610 A IL 20790610A IL 207906 A0 IL207906 A0 IL 207906A0
Authority
IL
Israel
Prior art keywords
ocular
treatment
related disorders
disorders
Prior art date
Application number
IL207906A
Other languages
English (en)
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of IL207906A0 publication Critical patent/IL207906A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
IL207906A 2008-03-10 2010-08-31 Treatment for ocular-related disorders IL207906A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3507308P 2008-03-10 2008-03-10
PCT/US2009/036119 WO2009114373A1 (en) 2008-03-10 2009-03-05 Treatment for ocular-related disorders

Publications (1)

Publication Number Publication Date
IL207906A0 true IL207906A0 (en) 2010-12-30

Family

ID=40583469

Family Applications (1)

Application Number Title Priority Date Filing Date
IL207906A IL207906A0 (en) 2008-03-10 2010-08-31 Treatment for ocular-related disorders

Country Status (22)

Country Link
EP (1) EP2285378A1 (ko)
JP (1) JP2011513488A (ko)
KR (1) KR20110009084A (ko)
CN (1) CN101965188A (ko)
AR (1) AR070975A1 (ko)
AU (1) AU2009223501A1 (ko)
BR (1) BRPI0909659A2 (ko)
CA (1) CA2717991A1 (ko)
CL (1) CL2009000551A1 (ko)
CO (1) CO6290691A2 (ko)
CR (1) CR11644A (ko)
DO (1) DOP2010000266A (ko)
IL (1) IL207906A0 (ko)
MA (1) MA32211B1 (ko)
MX (1) MX2010008308A (ko)
NI (1) NI201000131A (ko)
NZ (1) NZ587906A (ko)
RU (1) RU2010141560A (ko)
SV (1) SV2010003658A (ko)
TW (1) TW200950784A (ko)
WO (1) WO2009114373A1 (ko)
ZA (1) ZA201005337B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR074776A1 (es) 2008-12-18 2011-02-09 Sanofi Aventis Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente
EP2441755A1 (en) 2010-09-30 2012-04-18 Almirall, S.A. Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA005212B1 (ru) * 1999-12-24 2004-12-30 Авентис Фарма Лимитед Азаиндолы
AU778417B2 (en) * 2000-02-25 2004-12-02 Merck & Co., Inc. Tyrosine kinase inhibitors
KR20140025610A (ko) * 2005-09-30 2014-03-04 미카나 테라퓨틱스, 인크. 치환된 피라졸 화합물
CL2007002617A1 (es) * 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.

Also Published As

Publication number Publication date
CR11644A (es) 2010-11-22
EP2285378A1 (en) 2011-02-23
SV2010003658A (es) 2011-01-31
BRPI0909659A2 (pt) 2015-09-22
CN101965188A (zh) 2011-02-02
KR20110009084A (ko) 2011-01-27
AU2009223501A1 (en) 2009-09-17
RU2010141560A (ru) 2012-04-20
JP2011513488A (ja) 2011-04-28
ZA201005337B (en) 2011-04-28
MA32211B1 (fr) 2011-04-01
AR070975A1 (es) 2010-05-19
CA2717991A1 (en) 2009-09-17
NI201000131A (es) 2011-09-29
CO6290691A2 (es) 2011-06-20
WO2009114373A1 (en) 2009-09-17
MX2010008308A (es) 2010-08-11
NZ587906A (en) 2011-12-22
TW200950784A (en) 2009-12-16
DOP2010000266A (es) 2010-09-30
CL2009000551A1 (es) 2009-08-21

Similar Documents

Publication Publication Date Title
HK1212883A1 (zh) 治療眼部疾病的方法
WO2010144865A9 (en) Methods for treating gastrointestinal disorders
IL213619A0 (en) Treatment
GB0802116D0 (en) Treatment
IL253293B (en) Desferrioxamine complexes of metals for the treatment of diseases related to the immune system
ZA201203342B (en) Treatments for gastrointestinal disorders
EP2307035A4 (en) TREATMENT OF EPILEPSY
EP2175873A4 (en) TREATMENT OF FEARING STATES
GB2467710B (en) Methods for treating social disorders
GB0822011D0 (en) Treatment
EP2323681A4 (en) METHODS OF TREATING VIRAL CONDITIONS
IL218321A0 (en) Therapeutic agent for mood disorders
GB0811992D0 (en) Treatment
GB0702537D0 (en) Treatment for excessive adiposity
EP2240192A4 (en) TREATMENT OF DERMATOLOGICAL SUFFERING
IL207906A0 (en) Treatment for ocular-related disorders
GB0802201D0 (en) Treatment system
GB0820972D0 (en) Treatment
PT2278962E (pt) Métodos para o tratamento de desordens dermatológicas
IL213287A0 (en) Treatment for glomerulonephritis
GB0805912D0 (en) Treatment
GB0823273D0 (en) Treatment system
GB0816892D0 (en) Treatment
GB0820534D0 (en) Treatment
GB0821093D0 (en) Treatment